Home
Companies
Pfizer
Clinical Trials

Clinical Trials Related to Pfizer

Related studies linked through entity extraction aliases.

A Study To Investigate Palbociclib (PD-0332991) Pharmacokinetics In Healthy Subjects Of Japanese Descent Relative To Healthy Non-Asian Subjects, And To Determine If Changes In Palbociclib Dose Result In Proportional Changes In Palbociclib Plasma Exposure In Japanese Subjects

Status: COMPLETED
Phase: PHASE1

A Drug Interaction Study Between Bosutinib And Aprepitant In Healthy Volunteers

Status: COMPLETED
Phase: PHASE1

A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy

Status: COMPLETED
Phase: PHASE2

Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects

Status: COMPLETED
Phase: PHASE2

A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug Given With Canagliflozin In Adults With Type 2 Diabetes Mellitus Taking Metformin

Status: TERMINATED
Phase: PHASE2

A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug On Adults With Type 2 Diabetes Mellitus Taking Metformin

Status: TERMINATED
Phase: PHASE2

A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 To 85 Years, Who Will Each Receive 3 Doses Of Vaccine.

Status: COMPLETED
Phase: PHASE1

A Phase II Study of Dacomitinib in Progressive Brain Metastases

Status: TERMINATED
Phase: PHASE2

A Study To Evaluate The Safety And Tolerability Of PF-06342674 (RN168) In Subjects With Multiple Sclerosis (MS)

Status: TERMINATED
Phase: PHASE1

Pharmacokinetics And Relative Bioavailability Of Bococizumab (PF-04950615; RN316) When Administered To The Abdomen, Thigh Or Upper Arm

Status: COMPLETED
Phase: PHASE1

Study to Evaluate Resistance Mechanisms and Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients

Status: UNKNOWN
Phase: N/A

Relative Bioavailability Of Palbociclib (PD-0332991) Under Fed And Fasted Conditions

Status: COMPLETED
Phase: PHASE1

Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer

Status: COMPLETED
Phase: PHASE2

Dacomitinib Plus PD-0325901 in Advanced KRAS Mutant NSCLC

Status: COMPLETED
Phase: PHASE1/PHASE2

A Study Of PF-04449913 In Japanese Patients With Select Hematologic Malignancies

Status: COMPLETED
Phase: PHASE1

A Study To Assess The Safety Of PF-06342674 In Adults With Type 1 Diabetes

Status: COMPLETED
Phase: PHASE1

Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)

Status: COMPLETED
Phase: PHASE3

Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or ROS1

Status: COMPLETED
Phase: PHASE2

A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study)

Status: TERMINATED
Phase: PHASE2

13-valent Pneumococcal Conjugate Vaccine Study in Adults and Children in India

Status: COMPLETED
Phase: PHASE4